Clinical Trials
59 trialsAlkagin Paste in the Prevention of Radiation Dermatitis
Sir Mortimer B. Davis - Jewish General Hospital
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
National Cancer Institute (NCI)
Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer
National Cancer Institute (NCI)
Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study
Eastern Cooperative Oncology Group
Chase
Fudan University
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
Ohio State University Comprehensive Cancer Center
Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection
AIDS Malignancy Consortium
ANTARES
Instituto do Cancer do Estado de São Paulo
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
Hoosier Cancer Research Network
MAESTRO
University Health Network, Toronto
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Rutgers, The State University of New Jersey
HPV ctDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Advanced-Stage Anal Cancer
Case Comprehensive Cancer Center
Tamarack
MacroGenics
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
University of Washington
Potlako+
Brigham and Women's Hospital
Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV
Weill Medical College of Cornell University
KEYNOTE 158
Merck Sharp & Dohme LLC
SCARCE
GERCOR - Multidisciplinary Oncology Cooperative Group
Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer
AIDS Malignancy Consortium
ACROPOLI
SOLTI Breast Cancer Research Group
PEVOsq
UNICANCER
INTERACT-ION
Centre Hospitalier Universitaire de Besancon
PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients
Sun Yat-sen University
Proton Therapy in Reducing Toxicity in Anal Cancer
University of Cincinnati
RADIANCE
Goethe University
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers
M.D. Anderson Cancer Center
HETERERO
Charite University, Berlin, Germany
SPARTANA
Centre Hospitalier Universitaire de Besancon
Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study
M.D. Anderson Cancer Center
VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2
Inovio Pharmaceuticals
Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer
Eastern Cooperative Oncology Group
Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial
M.D. Anderson Cancer Center
InterAACT
Eastern Cooperative Oncology Group
Pembrolizumab in Metastatic Anal Cancer
Dana-Farber Cancer Institute
REFIT-MSS
Translational Research in Oncology
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
M.D. Anderson Cancer Center
M7824 in Subjects With HPV Associated Malignancies
National Institutes of Health Clinical Center (CC)
A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal
Advaxis, Inc.
A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine
Beijing Health Guard Biotechnology, Inc
BISQUIT
AC Camargo Cancer Center
HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL
University Health Network, Toronto
ReRad III
University of Aarhus
Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males
AIDS Malignancy Consortium
AIJP
University of California, San Francisco
Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer
UNICANCER
CARACAS
Gruppo Oncologico del Nord-Ovest
Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men
Centre hospitalier de l'Université de Montréal (CHUM)
[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers
University of Iowa
Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
Radiation Therapy Oncology Group
VITAL
Grupo Espanol Multidisciplinario del Cancer Digestivo